Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2024-01-03 Capital/Financing Update
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Reset Offers extension and change of General Meeting date 3 pages 282.0KB
Capital/Financing Update Classification · 95% confidence The document is an announcement from Little Green Pharma Ltd regarding the extension of a capital raising offer and the rescheduling of an Extraordinary General Meeting (EGM) related to a demerger and in-specie distribution of shares. It provides updated dates for the capital raising offer closing and the EGM, instructions for voting and participation, and a timetable for related events. The content focuses on shareholder meeting arrangements and capital raising updates rather than presenting financial statements or detailed financial results. The document is not a full financial report, audit, or earnings release, nor is it a proxy solicitation or voting results announcement. It is primarily an update on financing activities and meeting logistics related to the capital raising and demerger. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (5442 characters) supports it being a substantive announcement rather than a brief notice or report publication announcement.
2024-01-03 English
Updated Appendix 3A.5 11 pages 323.8KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3A.5 Notification of return of capital by way of in specie distribution of securities in another entity' and contains detailed information about the return of capital process, including entity details, approvals, and timetable for the return of capital. It references ASX (Australian Securities Exchange) regulatory forms and compliance with the Corporations Act. The content is a formal notification about a capital return event, specifically an in specie distribution, which is a type of capital restructuring. This is not a full financial report, earnings release, or management discussion, but a regulatory announcement related to capital changes. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as returns of capital.
2024-01-03 English
Updated Appendix 3A.5 11 pages 306.8KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3A.5 Notification of return of capital by way of in specie distribution of securities in another entity' and is addressed to the ASX (Australian Securities Exchange). It contains detailed information about the return of capital process, including entity details, approvals, timetable, and specifics about the in specie distribution. The document is a formal notification related to a capital return event, specifically a return of capital by way of in specie distribution, which is a capital/financing activity. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about a capital structure change. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2023-12-11 English
Change of date of General Meeting and Reset Offers 2 pages 211.4KB
Regulatory Filings Classification · 95% confidence The document is a notification from the Board of Little Green Pharma Ltd about the change of date for an Extraordinary General Meeting (EGM) and related offers. It provides details about the new meeting date, voting instructions, and an indicative timetable for related corporate actions. There is no financial data, no detailed report content, and no mention of actual financial results or management discussion. The document is essentially an announcement about the scheduling and procedural changes for a shareholder meeting and related offers. It does not contain the meeting materials themselves, voting results, or proxy solicitation materials. Therefore, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2023-12-10 English
LGP to capitalise on new French cannabis healthcare laws 4 pages 362.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 7 December 2023 from Little Green Pharma Ltd. It discusses the company's strategic position and benefits from new French legislation integrating medicinal cannabis into the healthcare system. The content focuses on regulatory changes, market opportunities, and the company's operational strategy in France. There are no financial statements, earnings data, or detailed financial analysis present. The document is a corporate announcement about regulatory and market developments rather than a financial report or detailed investor presentation. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is not a report publication announcement since it contains substantive company information rather than just announcing a report release. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about legislative changes affecting the company and its market strategy, which does not fit more specific categories.
2023-12-06 English
Half Yearly Report and Accounts 32 pages 916.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Year Financial Report' for the period ended 30 September 2023, indicating it is a financial report covering a half-year period. It includes detailed financial statements such as condensed consolidated statements of profit or loss, financial position, changes in equity, cash flows, notes to consolidated financial statements, directors' report, auditor's independence declaration, and independent auditor's review report. The content includes comprehensive financial data, operational review, CEO transition, market updates, and product developments. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2023-11-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.